In FGD patients, the specific impact of MCM4 variants is not fully understood; however, mouse models have shown a marked decrease in steroidogenic cells in adrenal zona fasciculata, thus suggesting a potential pathogenetic mechanism for MCM4-related FGD [7]. Here, MCM4 is linked to Aarskog-Scott syndrome, X-linked.